Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 16, 2026
TickeronGET DAILY SIGNALS
Entegris (ENTG): A Specialty Materials Play in the Semiconductor Supply Chain

Entegris (ENTG): A Specialty Materials Play in the Semiconductor Supply Chain

Key Takeaways

  • ENTG is the Nasdaq-listed ticker for Entegris, Inc., a supplier of critical advanced materials and process solutions for the semiconductor and other high-technology industries.
  • Headquartered in Billerica, Massachusetts, the company operates through two reportable segments: Materials Solutions and Advanced Purity Solutions.
  • Entegris generates most of its revenue from consumable products used repeatedly in chip manufacturing, which supports a relatively recurring sales base.
  • The company serves leading logic and memory chipmakers, semiconductor equipment manufacturers, and chemical and gas suppliers across Asia, North America, and Europe.
  • Key considerations for investors include customer concentration, exposure to the cyclical semiconductor market, geopolitical and trade risk, and significant debt carried from prior acquisitions.

Introduction

Entegris, Inc. (ENTG) sits at a pivotal point in the semiconductor supply chain as a specialty-materials provider. It develops and supplies advanced materials, filtration, purification, and contamination-control products that enable chipmakers to produce increasingly complex integrated circuits. Because these products are integral to the fabrication process, many investors view ENTG as a way to gain exposure to long-term semiconductor trends without direct investment in chipmakers or equipment vendors. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Company Overview and Business Model

Entegris traces its roots to 1966 and is headquartered in Billerica, Massachusetts. The company went public in 2000 and today employs roughly 7,700 people, with manufacturing, customer-service, and research facilities across North America, Asia, and Europe. Over time, Entegris has expanded through strategic transactions, including a 2019 combination with Versum Materials and the 2022 acquisition of CMC Materials, which broadened its portfolio of chemical mechanical planarization (CMP) and specialty-materials products.

Entegris reports its business through two segments. The Materials Solutions segment provides materials-based products such as deposition precursors, CMP slurries and pads, ion-implantation specialty gases, and formulated etch and clean chemistries. The Advanced Purity Solutions segment supplies filtration, purification, and contamination-control solutions that maintain the purity of liquid chemistries and gases and the cleanliness of wafers during manufacturing.

A defining feature of Entegris' business model is its emphasis on consumables. Many of its products are qualified into customers' highly standardized, or "copy exact," fabrication processes and must be replaced or replenished on an ongoing basis. This creates a relatively sticky, recurring revenue stream that is tied more closely to wafer volumes than to swings in factory construction spending. The company's financial profile reflects this model, with annual net sales in the range of roughly $3.2 billion and a majority of revenue generated outside North America.

Market Position and Key Markets

Entegris serves a broad set of customers across the semiconductor ecosystem, including logic and memory device manufacturers, semiconductor equipment makers, and chemical and gas suppliers. Its solutions address multiple steps in chip production, including photolithography, deposition, etch and clean, and ion implantation. The company also supplies adjacent high-technology markets such as flat-panel displays, data storage, and specialized industrial applications, though semiconductors remain the core of its business.

Geographically, Entegris' sales are weighted toward Asia, reflecting the concentration of global chip manufacturing in Taiwan, South Korea, China, and Japan, with additional contributions from North America and Europe. This global footprint positions the company close to the world's most advanced fabrication facilities while also exposing it to regional supply-chain and trade dynamics. From what I see, this positioning is important because it ties revenue directly to where the bulk of advanced chip production occurs.

Why Investors Follow ENTG

Investors follow ENTG primarily as a way to participate in long-term semiconductor growth. As chip architectures become more complex—driven by trends such as artificial intelligence, high-performance computing, and advanced packaging—manufacturers require increasingly pure materials and tighter contamination control. Entegris' co-optimized solutions across materials and purity give it a differentiated position, since it can combine chemistry, filtration, and fluid-handling expertise to help customers improve yields and device performance.

The company's recurring consumables revenue, diversified customer base, and high level of research-and-development investment are also central to its investment case. Entegris invests a meaningful percentage of sales in engineering and R&D, supporting its ability to develop products aligned with evolving chip technology roadmaps. One thing that stands out is how this R&D focus helps maintain relevance as process nodes shrink.

Risks and Important Considerations

Despite its strategic positioning, Entegris carries several risks that investors should understand. The semiconductor industry is cyclical, and demand for the company's products can soften during industry downturns. The company also has meaningful customer concentration: its largest customers account for a significant share of net sales, and a single major foundry has historically represented a notable portion of revenue. Geopolitical tensions and export controls, particularly those involving China, could affect sales and supply chains.

Entegris maintains substantial debt, much of it associated with the CMC Materials acquisition, which creates interest-rate exposure and financial obligations to manage alongside ongoing investment. The company also relies on sole or limited-source suppliers for certain raw materials, and its results are exposed to foreign-currency fluctuations given its global footprint. I'm watching this closely given ongoing trade uncertainties.

Exploring Tickeron’s AI Tools for Research

In my analysis of names like ENTG, I often turn to Tickeron’s AI Screener to quickly compare metrics across peers and spot patterns in technicals or fundamentals that might otherwise take hours to review manually. It helps surface ideas aligned with specific strategies without sifting through data one stock at a time, which keeps the research process efficient when evaluating semiconductor supply-chain opportunities.

Conclusion

Entegris occupies a distinctive niche within the semiconductor industry: it supplies the advanced materials and purity solutions that make modern, increasingly complex chip manufacturing possible. Its consumables-driven business model, global customer base, and focus on yield-critical products distinguish it from pure capital-equipment suppliers, while its exposure to industry cycles, customer concentration, and leverage remain important considerations. For investors seeking to understand the broader semiconductor value chain, Entegris offers a useful lens into the materials and processes that underpin advanced chip production.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ENTG

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


ENTG in downward trend: price dove below 50-day moving average on November 13, 2026

ENTG moved below its 50-day moving average on November 13, 2026 date and that indicates a change from an upward trend to a downward trend. In 42 of 50 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ENTG as a result. In 87 of 106 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.

The 10-day moving average for ENTG crossed bearishly below the 50-day moving average on November 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 74%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENTG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 62 cases where ENTG's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.

The Moving Average Convergence Divergence (MACD) for ENTG just turned positive on November 12, 2026. Looking at past instances where ENTG's MACD turned positive, the stock continued to rise in 39 of 51 cases over the following month. The odds of a continued upward trend are 76%.

Following a +12.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where ENTG advanced for three days, in 190 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.

ENTG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 135 of 175 cases where ENTG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. ENTG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 77 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.705) is normal, around the industry mean (5.670). P/E Ratio (63.672) is within average values for comparable stocks, (68.795). Projected Growth (PEG Ratio) (1.312) is also within normal values, averaging (0.801). Dividend Yield (0.003) settles around the average of (0.009) among similar stocks. P/S Ratio (5.984) is also within normal values, averaging (27.897).

The Tickeron Profit vs. Risk Rating rating for this company is 83 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENTG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock worse than average.

Notable companies

The most notable companies in this group are Applied Materials (NASDAQ:AMAT), Lam Research Corp (NASDAQ:LRCX), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 46.26B. The market cap for tickers in the group ranges from 310.74K to 665.22B. ASMLF holds the highest valuation in this group at 665.22B. The lowest valued company is SMTK at 310.74K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was 6%. For the same Industry, the average monthly price growth was -16%, and the average quarterly price growth was -35%. ONTO experienced the highest price growth at 18%, while SMTK experienced the biggest fall at -32%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was -32%. For the same stocks of the Industry, the average monthly volume growth was -12% and the average quarterly volume growth was -52%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 44
Price Growth Rating: 63
SMR Rating: 71
Profit Risk Rating: 76
Seasonality Score: 28 (-100 ... +100)
1-on-1 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of critical materials for the semiconductor, data storage, and pharmaceutical industries

Industry ElectronicProductionEquipment

Industry
Electronic Production Equipment
Address
129 Concord Road
Phone
+1 978 436-6500
Employees
7700
Web
https://www.entegris.com
Interact to see
Advertisement
The central price target used here is $400 , roughly 35% above Alphabet's latest verified closing price of $295.77 (November 13, 2026). This target is the arithmetic mean of verified analyst price targets reviewed, not a single analyst's forecast; independent data providers report comparable consensus averages in the high-$390s to low-$400s.
Upcoming catalysts: Integration of advertising into AI Overviews and Gemini conversations, the scaling of Gemini 3 and newer models across Search and Cloud, and the commercial ramp of the $32 billion Wiz cloud-security acquisition could all shape sentiment into 2026. Strategic positioning: Alphabet's vertically integrated artificial intelligence (AI) stack — from custom TPU (Tensor Processing Unit) chips to the Gemini models to Google Cloud — supports a durable, cost-advantaged position in the AI build-out.
The TETH exchange-traded fund (ETF) is the 21Shares Ethereum Staking ETF, a spot Ethereum fund listed on Cboe BZX, and it does not carry conventional analyst price targets. The $14 objective used here is a technical milestone discussed in public market commentary — roughly the zone where Ethereum could begin confirming a recovery — not an analyst consensus.
The central target of $6.70 is the arithmetic mean of seven recent, individually verified analyst price targets, rounded from $6.67. At a latest price near $3.70, reaching $6.70 would require roughly 81% upside — a very large move.
Lead catalyst: Chemomab has secured alignment with the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) on a single Phase 3 registration trial for nebokitug in primary sclerosing cholangitis (PSC), a rare liver disease with no approved disease-modifying therapy. Strategic pivot: A planned merger with Scipher Medicine is expected to close by year-end 2026, extending nebokitug into an AI-powered, precision-medicine Phase 2 trial in rheumatoid arthritis (RA).